NCT01902524View on ClinicalTrials.gov

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Chronic Pain
Interventions
DRUG

Fentanyl-TTS

All of the participants will receive the study drug at least once transdermally, administration dosage starts at 12.5 microgram/hour.

Trial Locations (1)

140-702

Asan Medical Center, Seoul

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01902524 - Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain | Biotech Hunter | Biotech Hunter